Background: Venous thromboembolism (VTE) has a long-term risk of recurrence, which can
be prevented by anticoagulation therapy. Methods and Results: The COMMAND VTE …

e480 bidity. Up to 40% of patients may suffer a recurrent event in their first 10 years after
diagnosis despite initial effective blood-thinning treatment, necessitating life-long therapy …

Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and
pulmonary embolism, is a common cardiovascular disease associated with significant …

Background We update recommendations on 12 topics that were in the 9th edition of these
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …

Methods The VTE Writing Group was established within THANZ and it comprised experts in
the field of thromboembolic disorders in Australia and New Zealand. All members undertook …

Venous thromboembolism (VTE) is a serious and often fatal medical condition with an
increasing incidence. The treatment of VTE is undergoing tremendous changes with the …

This review on the treatment of patients with venous thromboembolic disease consists of
three sections. The first section describes the epidemiology, natural history and reasons for …

Importance Many anticoagulant strategies are available for the treatment of acute venous
thromboembolism, yet little guidance exists regarding which drug is most effective and safe …

Background: Epidemiology and clinical management of acute venous thromboembolism
(VTE) are not readily available in Japan. Methods and Results: The Japan VTE Treatment …

Background Hereditary and acquired thrombophilia are risk factors for venous
thromboembolism (VTE). Whether testing helps guide management decisions is …